네비라핀 (Korean Wikipedia)

Analysis of information sources in references of the Wikipedia article "네비라핀" in Korean language version.

refsWebsite

Global rank Korean rank

16nih.gov

4^th place

15web.archive.org

1^st place

7doi.org

2^nd place

3^rd place

3boehringer-ingelheim.com

low place

2cdc.gov

218^th place

52^nd place

1drugs.com

399^th place

141^st place

1jamanetwork.com

2,650^th place

2,268^th place

1nejm.org

2,374^th place

1,850^th place

1harpers.org

6,640^th place

8,836^th place

1sagepub.com

731^st place

373^rd place

1clinicaltrials.gov

5,225^th place

4,327^th place

1aegis.com

low place

1fda.gov

447^th place

433^rd place

1aidsmap.com

low place

1mlo-online.com

low place

1worldcat.org

5^th place

11^th place

1semanticscholar.org

11^th place

310^th place

1researchgate.net

120^th place

222^nd place

1uspto.gov

1,459^th place

763^rd place

1i-base.info

low place

1state.gov

264^th place

397^th place

aegis.com

“Facts sheet from the AIDS Treatment Data Network”. 2006년 1월 13일에 원본 문서에서 보존된 문서. 2006년 1월 16일에 확인함.

aidsmap.com

Keith Alcorn (2010년 11월 16일). “Nevirapine / rifampicin interaction linked to higher recurrence of TB in people on ART”. 《Aidsmap》.

boehringer-ingelheim.com

bidocs.boehringer-ingelheim.com

cdc.gov

npin.cdc.gov

Panel on Treatment of HIV-Infected Pregnant Women and Prevention of Perinatal Transmission. Recommendations for use of antiretroviral drugs in pregnant HIV-1-infected women for maternal health and interventions to reduce perinatal HIV transmission in the United States. “Archived copy” (PDF). 2014년 4월 12일에 원본 문서에서 보존된 문서. 2014년 4월 11일에 확인함. . Accessed 16 November 2016.
Panel on Treatment of HIV-Infected Pregnant Women and Prevention of Perinatal Transmission. Recommendations for use of antiretroviral drugs in pregnant HIV-1-infected women for maternal health and interventions to reduce perinatal HIV transmission in the United States. “Archived copy” (PDF). 2014년 4월 12일에 원본 문서에서 보존된 문서. 2014년 4월 11일에 확인함. . Accessed 16 November 2016.

clinicaltrials.gov

“Archived copy”. 2008년 12월 5일에 원본 문서에서 보존된 문서. 2009년 1월 23일에 확인함.

doi.org

dx.doi.org

Johnson JA, Li JF, Morris L (Jul 2005). “Emergence of drug-resistant HIV-1 after intrapartum administration of single-dose nevirapine is substantially underestimated”. 《J Infect Dis》 192 (1): 16–23. doi:10.1086/430741. PMID 15942889.
Jourdain G, Ngo-Giang-Huong N, Le Coeur S (Jul 2004). “Intrapartum exposure to nevirapine and subsequent maternal responses to nevirapine-based antiretroviral therapy”. 《N Engl J Med》 351 (3): 229–40. doi:10.1056/NEJMoa041305. PMID 15247339.
Patel SS, Benfield P (Oct 1996). “New drug profile: nevirapine”. 《Clinical Immunotherapeutics》 6 (4): 307–317. doi:10.1007/BF03259093.
Schauer, Grant D.; Huber, Kelly D.; Leuba, Sanford H.; Sluis-Cremer, Nicolas (2014년 10월 13일). “Mechanism of allosteric inhibition of HIV-1 reverse transcriptase revealed by single-molecule and ensemble fluorescence”. 《Nucleic Acids Research》 (영어) 42 (18): 11687–11696. doi:10.1093/nar/gku819. ISSN 0305-1048. PMC 4191400. PMID 25232099.
Ren J, Bird LE, Chamberlain PP, Stewart-Jones GB, Stuart DI, Stammers DK (Oct 2002). “Structure of HIV-2 reverse transcriptase at 2.35-A resolution and the mechanism of resistance to non-nucleoside inhibitors”. 《Proc Natl Acad Sci USA》 99 (22): 14410–5. doi:10.1073/pnas.222366699. PMC 137897. PMID 12386343.
Montaner JS, Reiss P, Cooper D (Mar 1998). “A randomized, double-blind trial comparing combinations of nevirapine, didanosine, and zidovudine for HIV-infected patients: the INCAS Trial. Italy, The Netherlands, Canada and Australia Study”. 《JAMA》 279 (12): 930–7. doi:10.1001/jama.279.12.930. PMID 9544767.
Conway B, Wainberg MA, Hall D (Jul 2001). “Development of drug resistance in patients receiving combinations of zidovudine, didanosine and nevirapine”. 《AIDS》 15 (10): 1269–74. doi:10.1097/00002030-200107060-00008. PMID 11426071. S2CID 24944611.

drugs.com

“Nevirapine”. 《https://web.archive.org/web/20161220121202/https://www.drugs.com/monograph/nevirapine.html》. The American Society of Health-System Pharmacists. 2016년 12월 20일. 2016년 12월 3일에 확인함. |웹사이트=에 외부 링크가 있음 (도움말)

fda.gov

accessdata.fda.gov

“VIRAMUNE® (nevirapine) Prescribing Information” (PDF). 2016년 11월 8일에 원본 문서 (PDF)에서 보존된 문서.

harpers.org

Celia Farber, "Out of Control: AIDS and the Corruption of Science" “Archived copy”. 2009년 5월 4일에 원본 문서에서 보존된 문서. 2009년 6월 11일에 확인함.

i-base.info

“Once-daily nevirapine approved in Europe”. 《Once-daily nevirapine approved in Europe》. 2011년 10월 1일.

jamanetwork.com

Montaner JS, Reiss P, Cooper D (Mar 1998). “A randomized, double-blind trial comparing combinations of nevirapine, didanosine, and zidovudine for HIV-infected patients: the INCAS Trial. Italy, The Netherlands, Canada and Australia Study”. 《JAMA》. CS1 관리 - 여러 이름 (링크)

mlo-online.com

John Brunstein, PhD (John Brunstein, PhD). “Reverse transcriptase inhibitors: NRTIs vs NNRTIs”. 《MLO》.

nejm.org

Lallemant M, Gonzague Jourdain G, Sophie Le Coeur S, et al. (2004) Single-Dose Perinatal Nevirapine plus Standard Zidovudine to Prevent Mother-to-Child Transmission of HIV-1 in Thailand. N Engl J Med 351: 217-28, 보관됨 2006-06-18 - 웨이백 머신

nih.gov

ncbi.nlm.nih.gov

Johnson JA, Li JF, Morris L (Jul 2005). “Emergence of drug-resistant HIV-1 after intrapartum administration of single-dose nevirapine is substantially underestimated”. 《J Infect Dis》 192 (1): 16–23. doi:10.1086/430741. PMID 15942889.
Jourdain G, Ngo-Giang-Huong N, Le Coeur S (Jul 2004). “Intrapartum exposure to nevirapine and subsequent maternal responses to nevirapine-based antiretroviral therapy”. 《N Engl J Med》 351 (3): 229–40. doi:10.1056/NEJMoa041305. PMID 15247339.
Schauer, Grant D.; Huber, Kelly D.; Leuba, Sanford H.; Sluis-Cremer, Nicolas (2014년 10월 13일). “Mechanism of allosteric inhibition of HIV-1 reverse transcriptase revealed by single-molecule and ensemble fluorescence”. 《Nucleic Acids Research》 (영어) 42 (18): 11687–11696. doi:10.1093/nar/gku819. ISSN 0305-1048. PMC 4191400. PMID 25232099.
Ren J, Bird LE, Chamberlain PP, Stewart-Jones GB, Stuart DI, Stammers DK (Oct 2002). “Structure of HIV-2 reverse transcriptase at 2.35-A resolution and the mechanism of resistance to non-nucleoside inhibitors”. 《Proc Natl Acad Sci USA》 99 (22): 14410–5. doi:10.1073/pnas.222366699. PMC 137897. PMID 12386343.
Montaner JS, Reiss P, Cooper D (Mar 1998). “A randomized, double-blind trial comparing combinations of nevirapine, didanosine, and zidovudine for HIV-infected patients: the INCAS Trial. Italy, The Netherlands, Canada and Australia Study”. 《JAMA》 279 (12): 930–7. doi:10.1001/jama.279.12.930. PMID 9544767.
Conway B, Wainberg MA, Hall D (Jul 2001). “Development of drug resistance in patients receiving combinations of zidovudine, didanosine and nevirapine”. 《AIDS》 15 (10): 1269–74. doi:10.1097/00002030-200107060-00008. PMID 11426071. S2CID 24944611.
Joshua J Minuto, Richard Haubrich (2008 Nov 1). “Etravirine: a second-generation NNRTI for treatment-experienced adults with resistant HIV-1 infection”. 《Futur HIV Ther.》.

dailymed.nlm.nih.gov

“Viramune- nevirapine suspension Viramune- nevirapine tablet”. 《DailyMed》. 2019년 10월 28일. 2020년 11월 19일에 확인함.
“Viramune- nevirapine tablet, extended release”. 《DailyMed》. 2019년 10월 25일. 2020년 11월 19일에 확인함.
“Viramune- nevirapine suspension Viramune- nevirapine tablet”. 《DailyMed》. 2019년 10월 28일. 2020년 11월 19일에 확인함.
“Viramune- nevirapine tablet, extended release”. 《DailyMed》. 2019년 10월 25일. 2020년 11월 19일에 확인함.

aidsinfo.nih.gov

“Panel on Antiretroviral Therapy and Medical Management of HIV-Infected Children: Guidelines for the use of antiretroviral agents in pediatric HIV infection.”. AIDSinfo, U.S. Department of Health and Human Services (HHS). March 2016. 2016년 11월 7일에 원본 문서에서 보존된 문서. 2016년 11월 5일에 확인함.
DHHS panel. Guidelines for the use of antiretroviral agents in HIV-1-infected adults and adolescents (May 4, 2006). (Available for download from AIDSInfo 보관됨 2006-05-06 - 웨이백 머신)

pubmed.ncbi.nlm.nih.gov

Sonya J Snedecor 외 6인 (2013 Aug). “The prevalence of transmitted resistance to first-generation non-nucleoside reverse transcriptase inhibitors and its potential economic impact in HIV-infected patients”. 《PLoS One》.
“FDA approves first new class of HIV drugs. Food and Drug Administration”. 《AIDS Alert》. 1996 Aug.

www3.niaid.nih.gov

The HIVNET 012 Study and the Safety and Effectiveness of Nevirapine in Preventing Mother-to-Infant Transmission of HIV, “Archived copy”. 2009년 2월 1일에 원본 문서에서 보존된 문서. 2009년 1월 23일에 확인함.

researchgate.net

Karl Grozinger, John Proudfoot, Karl Hargrave (June 2006). “Discovery and Development of Nevirapine”. 《Current Opinion in Drug Discovery & Development》. CS1 관리 - 여러 이름 (링크)

sagepub.com

journals.sagepub.com

Johanna Crane (2010년 8월 17일). “Adverse events and placebo effects: African scientists, HIV, and ethics in the ‘global health sciences’”. SAGE Journals. 2021년 5월 5일에 확인함.

semanticscholar.org

api.semanticscholar.org

Conway B, Wainberg MA, Hall D (Jul 2001). “Development of drug resistance in patients receiving combinations of zidovudine, didanosine and nevirapine”. 《AIDS》 15 (10): 1269–74. doi:10.1097/00002030-200107060-00008. PMID 11426071. S2CID 24944611.

state.gov

2021 Annual Report to Congress (2021). “The United States President’s Emergency Plan for AIDS Relief”.

uspto.gov

patft.uspto.gov

“Uspto patient full-text and image database - Nevirapin”. 《Uspto patient full-text and image database》. 2018년 9월 20일에 원본 문서에서 보존된 문서. 2021년 5월 24일에 확인함.

web.archive.org

“Nevirapine”. 《https://web.archive.org/web/20161220121202/https://www.drugs.com/monograph/nevirapine.html》. The American Society of Health-System Pharmacists. 2016년 12월 20일. 2016년 12월 3일에 확인함. |웹사이트=에 외부 링크가 있음 (도움말)
“Panel on Antiretroviral Therapy and Medical Management of HIV-Infected Children: Guidelines for the use of antiretroviral agents in pediatric HIV infection.”. AIDSinfo, U.S. Department of Health and Human Services (HHS). March 2016. 2016년 11월 7일에 원본 문서에서 보존된 문서. 2016년 11월 5일에 확인함.
Lallemant M, Gonzague Jourdain G, Sophie Le Coeur S, et al. (2004) Single-Dose Perinatal Nevirapine plus Standard Zidovudine to Prevent Mother-to-Child Transmission of HIV-1 in Thailand. N Engl J Med 351: 217-28, 보관됨 2006-06-18 - 웨이백 머신
The HIVNET 012 Study and the Safety and Effectiveness of Nevirapine in Preventing Mother-to-Infant Transmission of HIV, “Archived copy”. 2009년 2월 1일에 원본 문서에서 보존된 문서. 2009년 1월 23일에 확인함.
Celia Farber, "Out of Control: AIDS and the Corruption of Science" “Archived copy”. 2009년 5월 4일에 원본 문서에서 보존된 문서. 2009년 6월 11일에 확인함.
“Archived copy”. 2008년 12월 5일에 원본 문서에서 보존된 문서. 2009년 1월 23일에 확인함.
Panel on Treatment of HIV-Infected Pregnant Women and Prevention of Perinatal Transmission. Recommendations for use of antiretroviral drugs in pregnant HIV-1-infected women for maternal health and interventions to reduce perinatal HIV transmission in the United States. “Archived copy” (PDF). 2014년 4월 12일에 원본 문서에서 보존된 문서. 2014년 4월 11일에 확인함. . Accessed 16 November 2016.
Viramune (nevirapine) tablets; Viramune (nevirapine) oral suspension prescribing information 보관됨 2006-11-12 - 웨이백 머신
“Facts sheet from the AIDS Treatment Data Network”. 2006년 1월 13일에 원본 문서에서 보존된 문서. 2006년 1월 16일에 확인함.
DHHS panel. Guidelines for the use of antiretroviral agents in HIV-1-infected adults and adolescents (May 4, 2006). (Available for download from AIDSInfo 보관됨 2006-05-06 - 웨이백 머신)
Panel on Treatment of HIV-Infected Pregnant Women and Prevention of Perinatal Transmission. Recommendations for use of antiretroviral drugs in pregnant HIV-1-infected women for maternal health and interventions to reduce perinatal HIV transmission in the United States. “Archived copy” (PDF). 2014년 4월 12일에 원본 문서에서 보존된 문서. 2014년 4월 11일에 확인함. . Accessed 16 November 2016.
“VIRAMUNE® (nevirapine) Prescribing Information” (PDF). 2016년 11월 8일에 원본 문서 (PDF)에서 보존된 문서.
Viramune (nevirapine) tablets; Viramune (nevirapine) oral suspension prescribing information 보관됨 2006-11-12 - 웨이백 머신
Viramune (nevirapine) tablets; Viramune (nevirapine) oral suspension prescribing information 보관됨 2006-11-12 - 웨이백 머신
“Uspto patient full-text and image database - Nevirapin”. 《Uspto patient full-text and image database》. 2018년 9월 20일에 원본 문서에서 보존된 문서. 2021년 5월 24일에 확인함.

worldcat.org

Schauer, Grant D.; Huber, Kelly D.; Leuba, Sanford H.; Sluis-Cremer, Nicolas (2014년 10월 13일). “Mechanism of allosteric inhibition of HIV-1 reverse transcriptase revealed by single-molecule and ensemble fluorescence”. 《Nucleic Acids Research》 (영어) 42 (18): 11687–11696. doi:10.1093/nar/gku819. ISSN 0305-1048. PMC 4191400. PMID 25232099.